Poly Group, founded with a mission to revolutionize antimicrobial solutions, specializes in developing patented, biocompatible antimicrobial technology. Their core product, Nouvex™, is a co-polymer that provides persistent antimicrobial protection by effectively killing bacteria and viruses. This technology is designed for long-lasting efficacy, making it suitable for various applications, particularly in the medical field where hygiene and safety are paramount.
Notable figures associated with Poly Group include its experienced management team and board of managers, who bring extensive expertise in biotechnology and business development. The company has achieved significant milestones, including the successful patenting of its Nouvex™ technology and its integration into various products. Poly Group's innovations have had a substantial impact on improving cleanliness and safety standards in healthcare environments, contributing to better health outcomes and reduced infection rates.
